New 52 Week High Today

Stock is Ex-Dividend Today

LeMaitre Vascular Inc LMAT:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
78.07UNCH (UNCH)
Volume
2,444
Close
78.07quote price arrow up+0.19 (+0.24%)
Volume
105,926
52 week range
44.27 - 79.19
Loading...
  • Open78.70
  • Day High79.19
  • Day Low77.71
  • Prev Close77.88
  • 52 Week High79.19
  • 52 Week High Date05/15/24
  • 52 Week Low44.27
  • 52 Week Low Date10/27/23

Key Stats

  • Market Cap1.752B
  • Shares Out22.45M
  • 10 Day Average Volume0.21M
  • Dividend0.64
  • Dividend Yield0.82%
  • Beta0.88
  • YTD % Change37.54

KEY STATS

  • Open78.70
  • Day High79.19
  • Day Low77.71
  • Prev Close77.88
  • 52 Week High79.19
  • 52 Week High Date05/15/24
  • 52 Week Low44.27
  • 52 Week Low Date10/27/23
  • Market Cap1.752B
  • Shares Out22.45M
  • 10 Day Average Volume0.21M
  • Dividend0.64
  • Dividend Yield0.82%
  • Beta0.88
  • YTD % Change37.54

RATIOS/PROFITABILITY

  • EPS (TTM)1.51
  • P/E (TTM)51.72
  • Fwd P/E (NTM)45.34
  • EBITDA (TTM)50.438M
  • ROE (TTM)11.65%
  • Revenue (TTM)199.887M
  • Gross Margin (TTM)66.45%
  • Net Margin (TTM)16.99%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/30/2024(est)
  • Ex Div Date05/15/2024
  • Div Amount0.16
  • Split Date-
  • Split Factor-

Latest On LeMaitre Vascular Inc

 

Profile

MORE
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue...
George LeMaitre
Chairman of the Board, Chief Executive Officer
David Roberts
President, Director
Joseph Pellegrino Jr.
Chief Financial Officer, Director
Giovannella Deiure
Vice President - Sales, Southern Europe
Helen Goulding
Vice President - Sales, Northern Europe
Address
63 2nd Ave
Burlington, MA
01803-4413
United States

Top Peers

SYMBOLLASTCHG%CHG
ESTA
Establishment Labs Holdings Inc
59.86+1.05+1.79%
CTKB
Cytek Biosciences Inc
6.10-0.20-3.17%
SILK
Silk Road Medical Inc
21.66+0.57+2.70%
STAA
STAAR Surgical Co
43.14-0.51-1.17%
RXST
Rxsight Inc
64.29+4.08+6.78%